Retinal diseases such as age-related macular degeneration (AMD) and diabetic retinopathy affect millions of people globally, often leading to vision loss with minimal straightforward treatment.
Add Yahoo as a preferred source to see more of our stories on Google. Golden Eye Gold dust in eyes might seem like an unusual therapy – but a new mouse study in the US shows the approach could ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today new, five-year efficacy, safety and durability data from the Phase ...
Stocktwits on MSN
OCUL stock surges overnight ahead of crucial wet AMD data readout, Sanofi takeover buzz builds
The company is set to release topline results from its Phase 3 superiority trial of Axpaxli in wet AMD on Tuesday. ・Ocular previously said that positive results could support a New Drug Application ...
An Ocular Therapeutix drug developed for the wet form of age-related macular degeneration was better at helping patients maintain vision compared to a blockbuster Regeneron Pharmaceuticals drug that ...
Julie Rosenthal, MD, MS, discusses the future direction of research into treating age-related macular degeneration.
Researchers think they know why eye injections for “wet” AMD sometimes fail The eye injections actually increase a protein linked to new blood vessel growth An experimental drug reduced levels of ...
Researchers at Science Tokyo developed an mRNA vaccine that suppressed abnormal retinal blood vessel growth in mouse models. The vaccine can be administered intramuscularly and showed effectiveness ...
Newmedica Worcester highlights AMD Awareness Month, urging early detection of age-related macular degeneration—the UK’s leading cause of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results